CoChat

Design, Synthesis, and Biological Activity of NCC149 Derivatives as Histone Deacetylase 8‐Selective Inhibitors

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

We recently discovered N‐hydroxy‐3‐[1‐(phenylthio)methyl‐1 H‐1,2,3‐triazol‐4‐yl]benzamide (NCC149) as a potent and selective histone deacetylase 8 (HDAC8) inhibitor from a 151‐member triazole compound library using a click chemistry approach. In this work, we present a series of NCC149 derivatives bearing various aromatic linkers that were designed and synthesized as HDAC8‐selective inhibitors. A series of in vitro assays were used to evaluate the newly synthesized compounds, four of which showed HDAC8 inhibitory activity similar to that of NCC149, and one of which displayed HDAC8 selectivity superior to that of NCC149. In addition, these top four compounds induced the increase of acetylated cohesin (an HDAC8 substrate) in HeLa cells in a dose‐dependent manner, indicating inhibition of HDAC8 in the cells. While none of these compounds enhanced the acetylation of H3K9 (a substrate of HDAC1 and 2), only one compound refrained from increasing α‐tubulin acetylation, a substrate of HDAC6, indicating that this compound is more selective for HDAC8 than the other derivatives. Furthermore, this HDAC8‐selective inhibitor suppressed the growth of T‐cell lymphoma cells more potently than did NCC149. These findings are useful for the further development of HDAC8‐selective inhibitors.

Overview

Integrity signals

Registry

Crossref · 10.1002/cmdc.201300414

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Research works printed but not linked: 1

  1. Yoshida M., 2003, Prog. Cell Cycle Res., 5, 269

Cited by

See all 81

Metadata

Authors
Suzuki, T., Muto, N., Bando, M., Itoh, Y., Masaki, A., Ri, M., Ota, Y., Nakagawa, H., Iida, S., Shirahige, K., & Miyata, N.
Affiliations
  • Nagoya City University (JP)
  • Institute for Quantitative Biosciences, The University of Tokyo (JP)
  • Kyoto Prefectural University of Medicine (JP)
Corresponding author
  • Suzuki, Takayoshi
  • Miyata, Naoki
Venue
ChemMedChem
Publisher
Wiley
Published
2014-01-08
Volume
9
Issue
3
Pages
657-664
ISSN
  • 1860-7179 (ISSN-L)
  • 1860-7187
OpenAlex
W2148310814
Cited by
71
References
26
Citations by year
2026: 5 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 8 · 2021: 7 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 7 · 2015: 5 · 2014: 3
FWCI
3.41
Type
journal article
Language
en
Open access
closed
Locations
  • ChemMedChem (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Japan Society for the Promotion of Science (24659050, 24689007)
  • Precursory Research for Embryonic Science and Technology
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
  • Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
Keywords
HDAC8 inhibitors, HDAC8, triazole derivatives, aromatic linkers, H3K9 acetylation, alpha-tubulin acetylation, T-cell lymphoma, enzyme selectivity
MeSH terms
Antineoplastic Agents, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, HeLa Cells, Histone Deacetylases, Humans, Hydroxamic Acids, Repressor Proteins, Structure-Activity Relationship, Triazoles, Drug Design, Molecular Structure, Cell Line, Tumor, Cell Proliferation, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.